Unlock stock picks and a broker-level newsfeed that powers Wall Street.
53.95
-0.39
(-0.72%)
At close: April 2 at 4:00:00 PM EDT
55.75
+1.80
+(3.34%)
Pre-Market: 6:32:46 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 0.92 | 0.91 | 4.51 | 4.96 |
| Low Estimate | 0.9 | 0.87 | 4.38 | 4.81 |
| High Estimate | 0.93 | 0.94 | 4.75 | 5.2 |
| Year Ago EPS | 0.95 | 0.94 | 3.71 | 4.51 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 17 | 18 |
| Avg. Estimate | 9.78B | 10.12B | 46.61B | 50.2B |
| Low Estimate | 9.6B | 9.84B | 43.7B | 46.62B |
| High Estimate | 10.47B | 10.62B | 53.55B | 57.06B |
| Year Ago Sales | 10.46B | 10.74B | 41.08B | 46.61B |
| Sales Growth (year/est) | -6.56% | -5.83% | 13.46% | 7.70% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.94 | 0.86 | 1.38 | 0.74 |
| EPS Actual | 0.95 | 0.94 | 1.54 | 0.68 |
| Difference | 0.01 | 0.08 | 0.16 | -0.06 |
| Surprise % | 1.32% | 9.05% | 11.72% | -7.53% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.92 | 0.91 | 4.51 | 4.96 |
| 7 Days Ago | 0.89 | 0.87 | 4.49 | 4.94 |
| 30 Days Ago | 0.9 | 0.87 | 4.52 | 4.98 |
| 60 Days Ago | 0.9 | 0.87 | 4.64 | 4.72 |
| 90 Days Ago | 0 | 0 | 4.85 | 5.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | 1 | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SNY | -3.48% | -3.42% | 21.54% | 10.08% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | Goldman Sachs: Neutral | 3/21/2025 |
| Maintains | Argus Research: Buy to Buy | 7/26/2024 |
| Initiated | Morgan Stanley: Equal-Weight | 1/23/2024 |
| Maintains | Argus Research: Buy | 3/27/2023 |
| Upgrade | Deutsche Bank: Sell to Hold | 8/12/2022 |
| Upgrade | SVB Leerink: Market Perform to Outperform | 9/27/2021 |
Related Tickers
NVS Novartis AG
110.77
+1.06%
GSK GSK plc
37.64
-0.61%
AZN AstraZeneca PLC
72.22
-0.52%
RHHBY Roche Holding AG
39.37
+0.15%
BMY Bristol-Myers Squibb Company
59.60
+0.08%
OGN Organon & Co.
14.72
+4.18%
BIIB Biogen Inc.
131.32
-0.54%
AMGN Amgen Inc.
305.70
-0.40%
GILD Gilead Sciences, Inc.
111.89
+0.55%
MRK Merck & Co., Inc.
86.60
-0.60%